An analysis of the total cohort showed that the parameters of age (P = 0.151), T stage (P = 0.111), N stage (P = 0.577), M stage (P = 0.095), pathologic stage (P = 0.084), primary therapy outcome (P = 0.962), race (P = 0.267), residual tumor (P = 0.721), anatomic neoplasm subdivision (Left/Right, P = 0.272; central/peripheral, P = 0.755), and tumor status (P = 0.311) were not associated with GCC2-AS1 expression. This evidence concerns the gene GCC2 and neoplasm.